Visit our Location
11860 Vista Del Sol Dr Suite 105,
El Paso, TX 79936
Give us a Call
+1 (915) 412-6680
Send us a Message
[email protected]
Opening Hours
Mon-Thu: 7 AM - 7 PM
Fri - Sun: Closed

Tag: micronized progesterone

ChiroMedBlogmicronized progesterone
Evidence-Based Integrative Hormone Care

Evidence-Based Integrative Hormone Care

Evidence-Based Integrative Hormone Care

Endometrial Health, Thrombosis Safety, Pain, Hair, and Patient-Centered Systems

Abstract

In this educational post, I walk you through how I design and deliver patient-centered, evidence-based care across hormones, endometrial health, thrombosis risk, pain and musculoskeletal function, hair physiology, and practical clinical systems. I explain the physiology behind each decision, why route and dose matter for estrogen, progesterone, and testosterone, how we interpret endometrial thickness and select biopsy methods, and why non-oral estradiol reduces the risk of venous thromboembolism. I share protocols to prevent testosterone-induced erythrocytosis, guide fertility counseling, and manage acne and hair shedding with a stable pharmacokinetic profile. Throughout, I show how integrative chiropractic care strengthens autonomic regulation, venous and lymphatic return, pelvic mechanics, and pain modulation, improving tolerance and outcomes. You will see the latest findings from leading researchers and how I apply them, visit by visit, with systems that keep patients supported and safe.

Introduction: My Integrative Approach to Complex Care

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In daily practice, I manage patients whose needs span endocrinology, gynecology, hematology, cardiometabolic health, neuromuscular pain, and performance. Excellent outcomes rarely depend on a single intervention; they come from a reliable care system: clear intake, structured follow-up, proactive side-effect management, and consistent communication. When we blend modern research methods with hands-on chiropractic-informed strategies and functional medicine principles, patients gain clarity, safety, and momentum.

What follows is the step-by-step journey I use to:

  • Align care with patient priorities through goal-concordant planning.
  • Choose hormone routes and doses that fit physiology and risk.
  • Interpret endometrial health with ultrasound, histology, and modern molecular adjuncts.
  • Reduce thrombosis risk using non-oral estrogen and careful testosterone monitoring.
  • Stabilize pain, sleep, and autonomic balance with integrative chiropractic care.
  • Manage hair health, acne, and metabolic drift with steady-state pharmacokinetics.
  • Build systems—checklists, schedules, micro-interventions—that make care predictable.

Core Patient-Centered Workflow: Systems that Prevent Dropout and Improve Safety

Patients judge success by whether we address their top three priorities. My system ensures those priorities drive decisions and scheduling:

  • Identify and document the patient’s top three goals at the start.
  • Pre-schedule next visits so that at least 90% leave with follow-up in place.
  • Use a structured side-effect checklist to detect issues early.
  • Apply communication scripts and provisional bookings to protect continuity.
  • Set a follow-up cadence: every 4–6 weeks for early stabilization, then extend based on lab and symptom stability.

Why this works: When patients can see the plan—and we guide them through it—adherence rises, and avoidable complications fall. Momentum prevents the stop-start patterns that lead to frustration, missed labs, and poor outcomes. My clinic observations at ChiroMed consistently show that pre-scheduled follow-ups and clear written care plans raise satisfaction and reduce detours (Chiromed.com; Jimenez, LinkedIn).

Integrative Chiropractic Care: The Physiologic Amplifier

Integrative chiropractic is not an add-on; it is a physiological amplifier. Hormones shift sleep, mood, vascular tone, and pain perception. When we optimize neuromuscular balance and autonomic function, patients tolerate medication better and experience smoother relief.

Key pillars and why they matter:

  • Autonomic regulation: Gentle spinal adjustments and soft-tissue work modulate the sympathetic-parasympathetic balance. Improved vagal tone supports sleep, digestion, and inflammatory resolution—critical when initiating progesterone, which exerts GABAergic sedative effects.
  • Pelvic mechanics and circulation: Restoring lumbosacral and pelvic girdle motion improves venous and lymphatic outflow, reducing pelvic congestion, cramping, and pressure that co-occur with abnormal bleeding.
  • Pain modulation: Manual therapy stimulates mechanoreceptors that dampen nociception and hyperalgesia. Fluctuating estrogen and progesterone can alter pain thresholds; chiropractic helps stabilize responses.
  • Exercise prescriptions: Low-impact strength, mobility, and breathing drills improve diaphragmatic tone, sleep quality, and recovery.

Clinical observations from my practice show that combining evidence-based medical therapy with chiropractic-guided plans produces better sleep, fewer pain flares, and a more stable mood (Chiromed.com; Jimenez, LinkedIn). This multimodal synergy creates sustainable improvement.

Progesterone Physiology and Practical Use: Sleep, Mood, and Endometrial Stability

Progesterone is central to managing abnormal uterine bleeding, sleep disturbances, and perimenopausal symptoms. Physiologically, progesterone:

  • Drives endometrial differentiation to the secretory state, countering estrogen’s proliferative effect.
  • Acts via neurosteroid metabolites like allopregnanolone on GABA-A receptors, producing anxiolytic and sedative effects that improve sleep.
  • Modulates inflammatory cytokine signaling, potentially reducing pelvic pain in inflammatory endometrial states.

Clinical indications:

  • Abnormal uterine bleeding when estrogen is relatively unopposed.
  • Sleep support during perimenopause and menopausal transitions.
  • Endometrial protection as part of estrogen therapy.

Formulation and dosing strategy:

  • Oral micronized progesterone (e.g., 200 mg at bedtime): Predictable systemic absorption and helpful somnolence when sleep support is desired. First-pass metabolism varies among patients, and some experience grogginess; we titrate dose and timing to align with goals.
  • Sublingual/buccal troches (e.g., 200 mg): Rapid absorption and reduced first-pass metabolism; less somnolence, preferred when daytime clarity is essential.
  • Quality matters: High-quality compounded formulations minimize excipient variability and allergen exposure (e.g., oil-based excipients), resulting in more consistent bioavailability and fewer erratic symptom cycles.

Why details matter: Align pharmacodynamics with patient goals. If sleepiness is helpful, we leverage it. If daytime function is critical, we shift to non-sedating schedules or formulations. Consistency builds confidence in the dose-response and reduces symptom cycling.

Endometrial Health: Thickness, Imaging, and Biopsy Decisions

The endometrium is highly responsive to hormonal balance. Ultrasound-measured endometrial thickness and tissue patterns guide risk stratification and biopsy decisions:

  • Thickness thresholds: In postmenopausal contexts, a properly timed ≤4 mm thickness often indicates a low immediate risk of endometrial carcinoma, per typical guidelines, when history and symptoms align.
  • Patterns and heterogeneity: Focal masses, polyps, or heterogeneous echotexture raise suspicion for polyps, hyperplasia, or neoplasia.
  • Biopsy selection:
    • Tissue biopsy remains the gold standard for histologic confirmation when imaging or symptoms indicate focal pathology or possible hyperplasia/cancer.
    • Liquid biopsy is an evolving adjunct that detects circulating tumor signals, promising but complementary to tissue histology for endometrial disease.

Clinical reasoning: If ultrasound shows benign features and low thickness while symptoms stabilize, the immediate cancer risk is low for that episode. Persistent or recurrent bleeding demands follow-through, regardless of a single reassuring test. We educate patients that good biopsy results are not the end of monitoring; symptoms still drive surveillance.

Hormone Routes and Thrombosis Safety: What Leading Research Shows

Route choice changes risk. Modern cohort analyses and meta-analytic data consistently demonstrate that oral estrogen induces hepatic synthesis of coagulation proteins, whereas transdermal estradiol bypasses the liver and is associated with neutral venous thromboembolism (VTE) risk in many populations.

What the data show:

  • Oral estrogen upregulates coagulation factors (e.g., factor VII and fibrinogen), thereby increasing VTE risk in some groups.
  • Transdermal estradiol has minimal effects on coagulation markers and is associated with neutral VTE profiles in large observational cohorts (Canonico et al., 2016; Vinogradova et al., 2019).
  • Micronized progesterone appears to have a neutral effect on VTE risk compared with certain synthetic progestins, which can increase risk when combined with oral estrogens (Stute et al., 2016).

Why I prefer non-oral starts:

  • For patients with prior clots, thrombophilias, or perioperative risk, non-oral estradiol protects hepatic coagulation balance.
  • Bedtime micronized progesterone synergizes with sleep architecture via GABAergic pathways.
  • Testosterone is best managed with carefully titrated non-oral options to avoid supraphysiologic peaks that can drive erythrocytosis.

Testosterone, Erythropoiesis, and Hematocrit: Mechanisms and Monitoring

Testosterone stimulates erythropoiesis by increasing erythropoietin (EPO) sensitivity and marrow response. Elevated hematocrit increases blood viscosity, especially above 52–54%, interacting with dehydration, smoking, and sleep apnea to raise risk.

My monitoring plan:

  • Baseline CBC, then at 3 months, 6 months, and every 6–12 months.
  • If hematocrit exceeds thresholds (e.g., 52–54%), lower the dose, extend intervals, evaluate for sleep apnea and hydration status, and consider therapeutic phlebotomy if indicated (Corona et al., 2014; Pastuszak et al., 2015).

Why dose matters: Erythrocytosis is dose-related and reversible. The goal is to maintain energy, libido, and mood benefits while keeping hematocrit within safe limits. We also coordinate with nephrology in CKD contexts to balance anemia management with hemodynamic safety.

Fertility and the Gonadal Axis: Counseling and Alternatives

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, lowering LH/FSH, reducing intratesticular testosterone, and decreasing sperm production. This effect is typically reversible over months after cessation.

Counseling steps:

  • Avoid starting testosterone when planning conception.
  • Consider HCG or SERMs under careful supervision to maintain intratesticular testosterone and support spermatogenesis.
  • Set expectations: recovery of sperm count can take up to 12 months, depending on baseline sperm count and the duration of suppression.

Stable Pharmacokinetics: Why Smooth Curves Beat Spikes

Short-acting hormonal modalities often create spike-and-crash profiles: transient peaks drive acne, irritability, fluid shifts, and receptor sensitization; troughs lead to fatigue and reduced efficacy. Longer-acting or split-dose strategies produce smoother curves with fewer adverse events.

Practical strategies:

  • Use smaller, more frequent injections to reduce peaks and troughs.
  • Prefer steady transdermal systems with consistent absorption.
  • Time labs relative to dosing to capture true troughs and peaks for precise titration (Pilz et al., 2015; Corona et al., 2022).

Clinical observation: Patients report dramatic improvements early after a large injection, then crash by day six. Dividing doses stabilizes energy and reduces acne. My ChiroMed experiences show better adherence and satisfaction when we minimize peaks and synchronize dosing with lifestyle and movement plans (Chiromed.com; Jimenez, LinkedIn).

Hair Physiology, DHT, and Shedding: Understanding the Transition

Hair cycles include anagen (growth) and telogen (shedding). When metabolism reactivates with hormone optimization, shedding can transiently increase as telogen hairs release to make room for new anagen growth. This is a transition, not failure.

Key points:

  • DHT (via 5-alpha-reductase) miniaturizes hair follicles in genetically susceptible individuals; testosterone itself does not directly cause hair loss without conversion to DHT and susceptibility.
  • Assess DHT, thyroid status, ferritin, vitamin D, and family history of androgenetic alopecia.
  • Manage DHT-driven loss with 5-alpha-reductase modulation when indicated, alongside scalp microcirculation support and mitochondrial health.

Supportive measures:

  • Nutritional optimization: protein, iron stores, B vitamins, and vitamin D near personalized targets.
  • Scalp care: minoxidil, gentle topicals for women, light-based therapies for men with sensitive skin.
  • Integrative strategies: diaphragmatic breathing and ribcage mobility to enhance perfusion and nitric oxide bioavailability; consider spermidine to support autophagy and follicle energetics (Holick, 2017; Eisenberg et al., 2019; Lanzillo et al., 2020).

Acne, Aromatization, and Dose Smoothing

Sharp androgen peaks stimulate sebaceous activity and keratinocyte proliferation. Smoother dosing profiles reduce acne. If aromatization spikes estradiol, we adjust testosterone dose before adding aggressive aromatase inhibition to protect bone and lipids. Skin protocols differ by sex and sensitivity:

  • Women: gentle salicylic acid; escalate to retinoids if needed; align with dose smoothing.
  • Men: if salicylic acid irritates, consider intense pulsed light (IPL), and prioritize pharmacokinetic smoothing.

Hypertension and Beta Blockers: Modern First-Line Reasoning

Beta blockers are no longer first-line for uncomplicated hypertension without compelling indications. Contemporary evidence favors thiazides, ACE inhibitors/ARBs, or calcium channel blockers for primary hypertension due to better stroke risk reduction and metabolic profiles (Wiysonge et al., 2017; Messerli et al., 2018).

What I do:

  • Reassess long-standing beta blocker use; confirm indications (post-MI, arrhythmias, heart failure).
  • Transition to guideline-preferred agents when appropriate.
  • Use chiropractic care to improve baroreflex sensitivity, breathing mechanics, and stress modulation; patients often experience more stable blood pressure variability along with movement prescriptions.

Infection Control and Post-Procedure Safety: Culture-Guided Action

Early post-procedure windows (days 7–14) are critical for catching wound complications before abscess formation. I schedule a 7-day in-person check and coach patients to send clear photos of their wounds if changes occur.

Why culture first:

  • Culture-guided therapy allows the use of narrow-spectrum antibiotics tailored to susceptibility, reduces resistance, and prevents symptom chasing.
  • If an abscess is present, perform incision and drainage; antibiotics alone cannot treat closed purulent collections (Stevens et al., 2014).
  • Build pre-op checklists (e.g., MSSA/MRSA screening and decolonization) and audit workflow compliance.

Chiropractic role:

  • Gentle autonomic regulation via breathing training and low-load mobility supports microcirculation and healing.
  • Regional joint mobilization (when cleared) assists lymphatic and venous return, reducing edema and discomfort.

Practical Medication Transitions: Sertraline and Tricyclics

Beyond hormones, careful pharmacology matters:

  • Sertraline titration should be gradual to avoid activation (anxiety, insomnia). Split dosing can moderate peak plasma concentrations.
  • Tricyclics require attention to CYP450 interactions and QT risk; space timing to avoid peak overlap and monitor EKG when indicated.
  • Reinforce sleep hygiene; poor sleep magnifies activation side effects and destabilizes autonomic tone.

Micro-Interventions and Clinical Checklists: Making Care Stick

High-performing clinics rely on checklists and short, repeatable micro-interventions:

  • Pre-procedure: screening for MSSA/MRSA, consent, wound care education, and scheduling the 7-day check.
  • Post-procedure: early re-check, cultures if draining, photo documentation, pain/function scoring.
  • Hormone transitions: lab scheduling, side-effect diaries, sleep-hygiene reinforcement, communication templates for primary care.

Five-minute interventions—breathing drills, posture resets, movement reminders—stacked across the week build habits, reduce pain, and support adherence without derailing clinic flow.

Putting It Together: A Patient Journey Example

I saw a patient for a scheduled 7-day post-procedure check. They reported mild redness and warmth:

  • We compared local temperature and tenderness to adjacent tissue, noted light serous drainage, and obtained a wound culture before antibiotics.
  • We set a 48–72 hour follow-up aligned to culture processing and documented their top priorities (pain reduction, return to work, and cosmetic healing).
  • Simultaneously, we planned a low-dose bridging approach for their transition from testosterone injections to a steadier regimen and aligned sleep and movement protocols (calf-pump activity and diaphragmatic breathing).
  • Result: targeted antibiotics matched the culture, swelling resolved, and the hormone transition proceeded with minimal side effects. Within four weeks, they met their top priorities and returned to training with improved energy and mood.

Why Integrative Chiropractic Belongs in This Care

The pelvis and spine are not isolated constructs; they interact with hormonal states, autonomic tone, and pain sensitivity. By improving joint mechanics, reducing muscle guarding, and supporting a parasympathetic shift, integrative chiropractic enhances the body’s ability to accommodate medication effects and heal.

Patients commonly report:

  • Better sleep onset and maintenance.
  • Reduced pelvic pressure and cramping.
  • Fewer anxiety flares during dose changes.
  • Enhanced energy and recovery.

My clinical observations reflect that this multimodal approach is both scientifically sensible and practically effective (Chiromed.com; Jimenez, LinkedIn).

Key Takeaways You Can Use Today

  • Prefer non-oral estradiol to minimize the impact on coagulation and VTE risk.
  • Use micronized progesterone at bedtime for endometrial protection and GABAergic sleep support.
  • Monitor hematocrit diligently with testosterone; adjust dose and intervals, assess OSA, hydration, and consider therapeutic phlebotomy when needed.
  • Stabilize pharmacokinetics: avoid short-acting spikes; divide doses for smoother curves.
  • Manage DHT thoughtfully; check thyroid and ferritin for hair health.
  • Employ culture-guided infection management; schedule a 7-day post-procedure check.
  • Build systems: checklists, side-effect diaries, pre-scheduled follow-ups, and micro-interventions.
  • Integrate chiropractic care to optimize autonomic regulation, venous return, pelvic mechanics, and pain modulation.

References

A Clinical Approach Overview on Bioidentical Hormones

Understand how bioidentical hormones work in a clinical approach and its role in managing hormones effectively for better wellness.

Abstract

Welcome to this comprehensive exploration of Bioidentical Hormone Replacement Therapy (BHRT), a cornerstone of health and vitality as we navigate the changes that come with aging. In this educational post, I, Dr. Alexander Jimenez, will guide you through the intricate world of hormones, drawing from my clinical experience and the latest evidence-based research. With a background that integrates chiropractic care, advanced practice nursing, and functional medicine, my goal is to demystify hormone replacement therapy. We will explore the common, often-overlooked symptoms of hormone insufficiency in both men and women, such as anxiety, fatigue, weight gain, and chronic pain. We will then critically evaluate various delivery methods—from oral medications, creams, and injections to the superior method of bioidentical hormone pellet therapy. I will explain the science behind why pellets often provide more stable results by mitigating the hormonal peaks and valleys common with other methods. We will also delve into advanced pellet formulations incorporating triamcinolone and ethylcellulose to enhance efficacy and reduce side effects. Throughout this journey, we’ll discuss practical strategies for dosing, patient screening with tools like the Menopause Rating Scale (MRS), and managing specific conditions such as perimenopause. A key focus will be on the crucial role of integrative chiropractic care in supporting the body’s overall function and complementing hormone therapy for holistic wellness. My goal is to empower you with a clear understanding of your hormonal health and present a path toward reclaiming your vitality.

Hello, I’m Dr. Alexander Jimenez. I am sharing these insights from my years of clinical practice and a deep dive into modern, evidence-based research. With my background as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), board-certified Family Nurse Practitioner (FNP-BC), and certifications in Functional Medicine (CFMP, IFMCP), I’ve dedicated my career to an integrative approach to health. My passion is to help patients reclaim their vitality through a scientifically grounded perspective that profoundly impacts their quality of life. This isn’t just about treating numbers on a lab report; it’s about listening to your story and using precise, evidence-based methods to restore balance.
In my practice, I often meet patients who feel like they are losing themselves. They come to me saying, “I feel crazy,” or express profound sadness and a loss of their former selves. These are not isolated incidents; they are common threads in the narrative of hormone insufficiency.

The Overlooked Symptoms of Hormone Insufficiency

Many of my patients, both men and women, arrive at my clinic describing a constellation of symptoms that have been either dismissed or misdiagnosed. It’s a story I hear daily.

  • Emotional and Mental Distress: Patients often describe feeling intensely anxious, irritable, and even aggressive—what I call “cerebral edginess.” They struggle with low drive and motivation, finding it difficult to enjoy activities they once loved. Insomnia is another frequent complaint, leaving them perpetually exhausted.
  • Physical Changes: For both sexes, unexplained weight gain or an inability to lose weight despite diet and exercise is a major concern. Men often report a significant lack of stamina and libido. While they may still have the desire, performance becomes an issue. Women, conversely, frequently experience a complete loss of libido. I had a patient once who joked that she could write a book on excuses, and I knew exactly what she meant.
  • Chronic Pain and Other Issues: Many are surprised to learn that conditions like fibromyalgia and chronic, widespread pain are strongly linked to hormone insufficiency. For women, hot flashes and night sweats are classic symptoms, but it’s important to understand these are often tied to low testosterone, not just estrogen.

Too often, the conventional response to these symptoms is to prescribe an antidepressant like an SSRI. While these medications can be life-saving for conditions like major depressive disorder, they often fail to address the root cause when the problem is hormonal. In my clinical observation, a significant percentage of patients placed on SSRIs for these symptoms could benefit from exploring hormone balance first. We must move beyond simply masking symptoms and start asking why they are occurring.

The Clinical Journey: Screening, Labs, and Treatment Planning

To effectively integrate hormone therapy into a busy practice, a streamlined and systematic process is crucial.

Step 1: Patient Screening and Documentation

The first step is identifying patients who could benefit from therapy. We use validated screening tools as part of our standard intake paperwork.

  • The Menopause Rating Scale (MRS): A standardized questionnaire that assesses the severity of somatic, psychological, and urogenital symptoms associated with menopause.
  • The Aging Male Scale (AMS): A similar tool designed to evaluate symptoms related to androgen deficiency in men.
  • These tools are invaluable. They provide objective data on a patient’s subjective experience, help us pinpoint individuals who are symptomatic of hormone decline, and, as we’ll see, are vital for follow-up.

Step 2: Foundational Lab Work to Establish Your Hormonal Baseline

You cannot manage what you do not measure. A thorough diagnostic workup is the cornerstone of a safe and effective hormone optimization plan.

  • Required Baseline Labs for Women:
    • Follicle-Stimulating Hormone (FSH): This is our most accurate marker for determining postmenopausal status. It operates on a classic negative feedback loop with estrogen. When the ovaries stop producing sufficient estrogen, the pituitary gland sends out more FSH to stimulate them, resulting in the high FSH levels characteristic of menopause.
    • Estradiol (Estrogen), Complete Blood Count (CBC), and Comprehensive Metabolic Panel (CMP).
  • Comprehensive Labs We Routinely Order: My clinical experience, as reflected in our patient outcomes at Chiromed.com, has shown that casting a wider net catches more underlying issues. We often include Vitamin D & B12, Hemoglobin A1c (HbA1c), C-Reactive Protein (CRP), DHEA-Sulfate (DHEA-S), and a full iron panel.

For my male patients, the panel is just as critical. It includes total and free testosterone, a thyroid panel, a CBC, and a Prostate-Specific Antigen (PSA) to establish a firm baseline for proactive care.

Step 3: The Consultation and Personalized Treatment Plan

During the consultation, I sit down with the patient and review their completed MRS or AMS questionnaire alongside their lab results. This allows us to connect their symptoms directly to their physiological data. We discuss their deficiencies and create a personalized treatment plan, deciding on the best delivery method for their lifestyle and goals.

Evaluating Hormone Replacement Therapy Options

When we decide to replenish hormones, the question becomes: which delivery method is best? Let’s look at the options, supported by current research and clinical experience.

Oral Medications

Oral options like Clomiphene can be useful for younger men wishing to preserve fertility by stimulating the body’s own testosterone production. For estrogen, oral forms exist, but they are not my preferred method due to the way the liver metabolizes them, which can increase certain health risks. Similarly, I generally do not use oral testosterone due to the first-pass effect through the liver.

Transdermal Creams and Gels

Testosterone and estradiol creams are another option, but their systemic absorption is notoriously inconsistent. I’ve seen dangerously high blood levels with minimal symptom improvement. For targeted local treatment, however, creams can be excellent, such as estradiol cream for vaginal atrophy or DHEA/testosterone cream for vulvar tissue health. For men, scrotal application offers the best absorption. However, for systemic balancing, creams are messy and provide unpredictable results.

Injections

Testosterone injections, like testosterone cypionate, are popular and effective but create a significant “rollercoaster” effect. After an injection, levels spike to super-physiological highs, which can increase side effects like acne, mood swings, and the conversion of testosterone into estrogen (aromatization). Then, as the week progresses, levels plummet, leading to a crash. A more modern approach I use is to split the weekly dose (e.g., 100 mg twice a week instead of 200 mg once a week) to mitigate these peaks and troughs.
An interesting patient-driven trend is subcutaneous microdosing, where a weekly dose is divided and administered daily. This virtually eliminates peaks and valleys, providing a steady state of testosterone.

Transdermal Patches

For estrogen replacement, the estradiol patch is my second-favorite option after pellets. Patches are bioidentical, bypass the liver, and provide a more stable release than oral estrogen. They are a good option for patients who do not want pellets.

The Superiority of Hormone Pellet Therapy

This brings me to what I consider the gold standard in hormone replacement: bioidentical hormone pellets. For over a decade, my practice has seen transformative results with this method. Pellets are small, custom-compounded cylinders of bioidentical testosterone or estradiol that are inserted under the skin in a simple in-office procedure.

Why Pellets Are Different

  • Consistent Hormone Levels: This is the single biggest advantage. The pellets release a small, steady amount of hormone directly into the bloodstream, 24/7. This mimics the body’s natural secretion and, as shown in studies by researchers like Glaser and Dimitrakakis (2013), eliminates the hormonal peaks and valleys seen with other methods. This stability translates to more consistent symptom relief.
  • Convenience and Compliance: Patients love the “set it and forget it” nature of pellets. Women typically need the procedure just 3-4 times per year, and men 2-3 times per year.
  • Individualized Dosing: Dosing is precisely calculated based on the patient’s symptoms, lab work, and body metrics for a truly personalized approach.
  • Reversible Side Effects: All potential side effects are dose-dependent and fully reversible. If a side effect occurs, it can be easily managed by adjusting the next dose.

Innovations in Pellet Compounding: The Next Level of Care

Not all pellets are created equal. The formulation and manufacturing process matter immensely.

The Role of Triamcinolone

Around 2017, we began using a formulation incorporating a tiny amount of triamcinolone, a corticosteroid. This was a game-changer. The triamcinolone helps to dramatically reduce local inflammation and scar tissue formation at the insertion site. Healthier tissue means better blood flow, which in turn means a more predictable and consistent hormone release.

Ethylcellulose for a Smoother Release

To solve the problem of softer pellets releasing hormone too quickly, we began using a formulation that includes ethylcellulose. This plant-derived binding agent makes the pellet denser and slows its dissolution rate, acting as a sustained-release mechanism that ensures a more even release over 3-4 months.

The Science of Horizontal Pellet Pressing

Most pharmacies press pellets vertically, leading to uneven density. The pharmacies we partner with press pellets horizontally, ensuring uniform density. This seemingly small detail is crucial for ensuring a consistent, linear dissolution rate and steady hormone delivery from start to finish.

Modulating Women’s Hormones-Video

Clinical Pearls: Practical Guidance for Common Scenarios

Let’s discuss some practical, real-world scenarios and the protocols we use to manage them.

Perimenopause: The 6 mg Estrogen Game-Changer

Perimenopause is arguably the most challenging phase for women. Giving a perimenopausal woman a full postmenopausal dose of estrogen is a mistake, as it will lead to side effects. The solution is a low-dose 6 mg estrogen pellet. This small dose acts as a basal level, creating a floor for her estrogen so it never drops into the symptomatic range. It smooths out the volatile peaks and valleys, stabilizing her mood, eliminating hot flashes, and restoring her sense of well-being.

The Critical Role of Progesterone

Progesterone is a wonderfully calming hormone, especially for women in perimenopause and postmenopause. Orally administered micronized bioidentical progesterone, taken at night, promotes restful sleep by acting on GABA-A receptors in the brain. In perimenopause, it can regulate periods and alleviate severe PMS. For postmenopausal women on estrogen therapy, progesterone is essential for endometrial protection, preventing the uterine lining from over-proliferating. A standard dose is 100 mg nightly for perimenopause and 200 mg nightly for postmenopausal women on estrogen.

Optimizing Testosterone and the Power of Shilajit

Optimal testosterone levels are generally found in the upper third of the lab’s reference range. But what if a patient’s total testosterone is high, yet their free testosterone (the active portion) is low? This is where a game-changing nutraceutical comes in: shilajit. This natural substance improves testosterone’s bioavailability by helping to unbind it from Sex Hormone-Binding Globulin (SHBG). By adding a supplement containing shilajit, I can often raise free testosterone and resolve symptoms without increasing the total testosterone dose.

The Role of Integrative Chiropractic Care

As a chiropractor, I see the body as an interconnected system. Hormone therapy does not exist in a vacuum. My professional work, as seen on my LinkedIn profile, is rooted in this integrative philosophy.

  • Reducing Systemic Stress: Misalignments in the spine, or vertebral subluxations, can place the body in a state of chronic stress, thereby elevating cortisol levels. High cortisol disrupts the entire endocrine system. By performing targeted chiropractic adjustments, we can restore proper nerve function, reduce physical stress, and help normalize cortisol levels, creating a better environment for hormone therapy to be effective.
  • Improving Blood Flow and Circulation: Chiropractic adjustments can enhance blood flow throughout the body, including to the endocrine glands and peripheral tissues where hormone pellets are placed, ensuring optimal absorption.
  • Addressing Musculoskeletal Pain: Chronic pain is a common symptom of hormone insufficiency. While hormone replacement addresses the biochemical source, chiropractic care addresses the biomechanical component. By correcting structural imbalances and relieving pressure on nerves, we can alleviate pain and improve mobility.

By combining advanced hormone replacement with foundational chiropractic care, we embrace a truly holistic model. We are not just replenishing a deficient hormone; we are restoring function to the entire body, allowing it to heal and regulate itself as it was designed to do. This synergy is powerful. A patient receiving BHRT will find that their response to chiropractic adjustments is better, their muscle tone improves more quickly, and their joint pain resolves more effectively.

The Power of Follow-Up and Validation

Our work doesn’t end after the first insertion. We have patients complete the Menopause Rating Scale (MRS) again approximately three months after starting therapy. Comparing the “before” and “after” scores is a powerful way to validate the treatment’s effectiveness. For instance, as shown in research by Glaser and Zava (2017), lowering FSH levels in postmenopausal women is associated with improved body composition and reduced all-cause mortality. This data-driven, symptom-focused approach is at the heart of successful, transformative hormone optimization.

References

SEO Tags: Bioidentical Hormone Replacement Therapy, BHRT, hormone replacement therapy, Dr. Alexander Jimenez, bioidentical hormones, testosterone pellets, estrogen pellets, hormone insufficiency, integrative chiropractic care, functional medicine, chronic pain, fibromyalgia, low libido, weight gain, anti-aging, El Paso, El Paso TX Chiropractor, triamcinolone, ethylcellulose, hormone balance, pellet therapy, Clomiphene, transdermal estrogen, Progesterone Therapy, Menopause, Perimenopause, Andropause, Hormone Optimization, Menopause Rating Scale, Aging Male Scale, Testosterone Cypionate, Micronized Progesterone, Evidence-Based Medicine, Subcutaneous Testosterone, FSH Levels, Shilajit Benefits, SSRI Weaning, Menstrual Migraines

Clinical Hormone Protocols and Chiropractic Support

Clinical Hormone Protocols and Chiropractic Support

Clinical Hormone Protocols and Chiropractic Support
A woman is in a consultation with a doctor in a clinic.

Abstract

In this educational post, I present a clear, first-person journey through modern, evidence-based approaches to common hormonal and metabolic challenges I see in practice: iron deficiency and heavy menstrual bleeding, PCOS management, post–gastric bypass considerations, testosterone therapy physiology, contraception risk-benefit decisions in midlife, SHBG-related treatment resistance, and progesterone strategy in premenopause, perimenopause, and menopause. I integrate clinical observations from my work as a chiropractor and advanced practice clinician and show how integrative chiropractic care fits within comprehensive, patient-centered protocols. I highlight practical dosing frameworks, explain underlying physiology—absorption, distribution, and renal excretion—and share how to avoid pitfalls with estrogen modulation, environmental exposures, and breast cancer risk. Throughout, I reference the latest research from leading investigators, link to sources, and offer stepwise algorithms and bullet-pointed checklists you can use in clinical decision-making.

Introduction: Why Multidisciplinary Care Matters in Hormone Health

In my clinical practice, I often begin by assembling the right team around the patient—endocrinology, primary care, women’s health, nutrition, behavioral health, and integrative chiropractic—to ensure we address physiology, biomechanics, lifestyle, and safety. Many of the cases discussed below involve overlapping contributors—iron deficiency, thyroid status, insulin resistance, post-surgical malabsorption, and altered sex-hormone binding globulin (SHBG). Without a comprehensive approach, patients can remain symptomatic despite reasonable therapies.

I use a structured framework:

  • Define the primary symptom drivers: bleeding, fatigue, mood, sleep, weight, libido, and cognition.
  • Screen for common physiological disruptors: iron deficiency, thyroid dysfunction, insulin resistance, chronic inflammation, micronutrient deficiencies, gut dysbiosis.
  • Model hormone kinetics: absorption, distribution, metabolism, and excretion.
  • Map risk-benefit: contraception, vascular risk (DVT), bone health, breast cancer.
  • Layer integrative chiropractic care: neuromusculoskeletal optimization, autonomic regulation, sleep and stress coaching, movement prescriptions, and pain reduction that support endocrine balance.

Iron Deficiency, Heavy Menstrual Bleeding, and Cyclic Progesterone

Many women I see have untreated or under-treated iron deficiency. Heavy menstrual bleeding leads to cumulative iron loss, lowering ferritin and impairing oxygen delivery and mitochondrial function. That drives fatigue, brain fog, exercise intolerance, hair thinning, and altered thermoregulation.

Key physiology:

  • Iron is essential for hemoglobin, myoglobin, mitochondrial electron transport (complexes I–IV), thyroid peroxidase activity, and neurotransmitter synthesis.
  • Low ferritin (<30–50 ng/mL in symptomatic patients) is commonly associated with fatigue, even when hemoglobin remains normal.
  • Copper supports ceruloplasmin and iron mobilization from stores. Low copper can blunt iron’s efficacy.

My evidence-based approach:

  • Assess CBC, ferritin, transferrin saturation, CRP (to interpret ferritin), TSH, free T4, free T3, and B12/folate.
  • Consider cyclic progesterone to stabilize the endometrium and reduce bleeding. In premenopausal heavy bleeding, physiologic micronized progesterone can reduce flow by limiting endometrial proliferation and enhancing orderly shedding.
  • Supplement iron with a well-tolerated chelate (e.g., ferrous bisglycinate) and co-factors:
    • Vitamin C to enhance non-heme iron absorption.
    • Copper (if low), magnesium, and B vitamins to support erythropoiesis.
  • Treat thyroid dysfunction as it contributes to menorrhagia and anemia by altering clotting factors and endometrial function.
  • Use dietary strategies: heme iron sources, polyphenols timed away from iron dosing, and avoiding inhibitors (tea/coffee) around iron intake.

Why cyclic progesterone helps:

  • Progesterone counterbalances estrogen-induced endometrial proliferation.
  • It improves spiral artery stability and reduces prostaglandin-mediated hyperperistalsis and cramping.
  • Cyclic dosing aligns with the luteal phase, supporting more physiologic endometrial responses.

Clinical checklist:

  • Confirm iron deficiency (ferritin and iron studies).
  • Initiate iron plus co-factors; schedule follow-up ferritin/TSAT.
  • Use cyclic micronized progesterone for 2–3 cycles and reassess bleeding.
  • Normalize thyroid function if abnormal.
  • Integrate chiropractic care to address fatigue-related deconditioning and pelvic floor mechanics.

PCOS: Insulin Resistance, Ovulatory Dysfunction, and Progesterone Use

In PCOS, I emphasize insulin-sensitizing strategies, cycle regulation, and endometrial protection.

PCOS physiology:

  • Hyperinsulinemia raises ovarian theca cell androgen production.
  • Altered GnRH pulsatility impairs ovulation; unopposed estrogen exposes the endometrium to proliferative signals, increasing the risk of heavy bleeding.
  • SHBG is often reduced by insulin resistance, increasing free androgens and symptoms (acne, hirsutism).

My protocol:

  • Lifestyle: progressive resistance and aerobic training; sleep optimization; high-fiber, low-glycemic diet; targeted weight reduction.
  • Metabolic supports: inositol (myo- and D-chiro), magnesium, vitamin D, omega-3s; consider metformin or GLP-1 agonists when indicated.
  • Cyclic progesterone can protect the endometrium and regulate bleeding in anovulatory cycles.
  • Monitor lipids, A1c, fasting insulin, LH/FSH ratio, and ultrasound where appropriate.

Why progesterone in PCOS:

  • Provides luteal-phase coverage to reduce endometrial proliferation.
  • May improve sleep and anxiety through GABAergic modulation, supporting adherence to lifestyle changes.

My clinical observation:

  • Adding cyclic progesterone while addressing insulin resistance reduces bleeding within 2–3 cycles and improves energy as ferritin normalizes.

Post–Gastric Bypass and Malabsorption: Gut, Micronutrients, and Hormone Therapy

Post-bariatric patients present unique challenges due to altered anatomy and absorption.

Physiology considerations:

  • Reduced gastric acid and bypassed segments alter the absorption of iron, B12, folate, calcium, vitamin D, and fat-soluble vitamins.
  • Microbiome changes and small intestinal bacterial overgrowth (SIBO) can impair nutrient uptake and mucosal integrity.

My approach:

  • Aggressively test and replace micronutrients: iron, B12, folate, vitamin D, calcium, magnesium, zinc, copper, selenium, vitamins A, E, and K.
  • Use probiotics tailored for upper and lower GI support and consider prebiotics if tolerated.
  • If oral iron is poorly absorbed, consider IV iron repletion.
  • For hormone therapies:
    • Prefer transdermal routes for estrogens/progestins to bypass first-pass metabolism and variable absorption.
    • Use subcutaneous pellet or injectable strategies judiciously, titrating based on symptoms and lab response.
  • Monitor markers of inflammation and renal function since excretion pathways (for testosterone pellets) are renal-dominant.

Integrative chiropractic fit:

  • Address post-surgical biomechanics, core stability, and autonomic balance to reduce pain and improve exercise tolerance, aiding insulin sensitivity and weight maintenance.

Testosterone Therapy Physiology: Absorption, Distribution, and Renal Excretion

When optimizing testosterone, I emphasize three kinetic pillars: absorption, distribution, and excretion.

  • Absorption: For transdermals and pellets, local blood flow and cardiac output matter. Greater capillary perfusion (e.g., regular exercise) increases uptake; patients with sedentary habits may exhibit slower rises.
  • Distribution: Testosterone disperses throughout total body water and adipose compartments. Higher BMI dilutes effective concentration; weight loss reduces distribution volume, potentially increasing exposure at a given dose.
  • Excretion: Testosterone and its metabolites are predominantly renally cleared. Older adults with reduced GFR maintain levels longer; lower doses often suffice with extended duration of effect.

Clinical implications:

  • After significant weight loss (e.g., 250 lb to 190 lb), prior dosing may over-expose; re-calculate based on body composition changes.
  • Elderly males may experience prolonged pellet duration (e.g., 6–9 months) due to slower clearance—dose conservatively and extend intervals.

Managing estrogenic symptoms:

  • Transient breast tenderness in early therapy often reflects a rapid rise in testosterone with aromatization to estradiol. This typically resolves after initial titration.
  • I avoid routine estrogen blockers unless there is clear evidence of persistent symptomatic hyperestrogenism; instead, I optimize dose, timing, and route.
  • If needed, I may use targeted nutraceuticals such as diindolylmethane (DIM) to support balanced estrogen metabolism, but I prefer to correct kinetics first.

Safety and performance myths:

  • Requests for “extra sessions” to get “jacked” rapidly are unsafe and unnecessary; supraphysiologic dosing risks adverse effects and paradoxical sexual dysfunction.
  • I counsel clearly: more is not better; tailored, steady-state physiology produces superior outcomes.

Midlife Contraception, DVT Risk, and Rational Alternatives

Risk-benefit changes with age. In my practice:

  • Young adults on oral contraceptives accept a modestly increased risk of venous thromboembolism (VTE) that often remains acceptable given high contraceptive utility.
  • By ages 40–45+, for women who no longer need contraception (e.g., IUD in place or tubal ligation), continued combined oral contraceptives may present unnecessary VTE and stroke risks.

Practical steps:

  • If the goal is symptom control (PMS, dysmenorrhea, endometriosis), I prefer non-contraceptive hormone strategies: micronized progesterone, low-dose transdermal estradiol balanced with progesterone, or levonorgestrel IUD for local endometrial control.
  • I avoid systemic estrogen-progestin contraceptives in midlife when contraception is not needed.
  • Integrate SHBG dynamics in the decision: high SHBG often blunts the free testosterone response.

SHBG, Free Testosterone, and Clinical Resistance

I frequently see midlife women with high SHBG (e.g., ~115 nmol/L) who report minimal benefit until total testosterone is pushed high—an approach I generally avoid.

Physiology:

  • SHBG binds testosterone and estradiol. Higher SHBG levels reduce free fractions, leading to symptomatic “non-response” despite normal total levels.
  • Estrogen-containing contraceptives elevate SHBG; hyperthyroidism, liver disease, and genetics also contribute.

My strategy:

  • Lower SHBG is influenced by changing the hormonal milieu rather than forcing total testosterone upward.
    • Replace combined oral contraceptives with a levonorgestrel IUD to minimize systemic estrogen contribution to SHBG.
    • Address thyroid status, liver health, and insulin resistance.
  • Aim to optimize free testosterone within physiologic ranges, not inflate total values.

Clinical pearl:

  • Women with high SHBG are often difficult to satisfy symptomatically if contraceptives remain unchanged. Shifting to an IUD and carefully titrating physiological dosing improves mood, energy, libido, and reduces the risk of adverse events.

Progesterone in Premenopause vs Perimenopause and Menopause

I differentiate between contraceptive progestins and physiologic progesterone:

  • In premenopause, progestins in combined oral contraceptives primarily prevent ovulation and pregnancy; they are not designed for symptom modulation alone.
  • In perimenopause and menopause, micronized progesterone is used therapeutically to treat symptoms: sleep disturbance, anxiety, vasomotor instability, and heavy bleeding. It is bioidentical, engages GABA-A receptors, and provides endometrial protection when used with estradiol.

Why use micronized progesterone:

  • Better tolerability and neurosteroid benefits.
  • Lower thrombotic risk compared to some synthetic progestins when paired with transdermal estradiol.
  • Improves sleep architecture and reduces night sweats.

Risk considerations:

  • Certain synthetic progestins combined with oral estrogens may elevate breast cancer risk compared to regimens using transdermal estradiol plus micronized progesterone; I tailor choices based on family history, prior exposures, and current evidence.

Addressing Environmental Exposures and SHBG Modifiers

Patients often ask whether environmental toxins (e.g., lead) significantly alter SHBG or testosterone responses. My stance:

  • While some supplements claim to reduce SHBG by 10–15%, such modest shifts rarely translate to meaningful clinical benefit without changing the hormonal environment.
  • I prioritize root-cause changes: removing exogenous estrogens, stabilizing thyroid and liver function, improving metabolic health, and fine-tuning hormone dosing and route.

Pellet Dosing, Durability, and Renal Considerations

Pellet therapy can be effective when applied thoughtfully:

  • I avoid nightly “stacking” of transdermal testosterone at uniform high doses; chronic overexposure risks dysregulation and breakthrough issues.
  • For heavy bleeding cases, I may cycle a structured progesterone regimen for several months to stabilize the endometrium before introducing or escalating other therapies.
  • In elderly men, reduced renal clearance extends pellet longevity; I plan for longer intervals and lower insertions.

Erectile Dysfunction and Testosterone: Clarifying Misconceptions

I am often asked whether atrial fibrillation or cardioversion interacts adversely with testosterone. Findings suggest:

  • Men with androgen deficiency who normalize testosterone prior to certain cardiac procedures may experience improved outcomes, likely through metabolic and autonomic stabilization.
  • Erectile dysfunction (ED) is multifactorial—vascular, neurologic, and endocrine—and not inherently caused by appropriate testosterone replacement. Careful titration minimizes risks.

I emphasize:

  • Keep hematocrit in the mid-normal range; monitor hemoglobin and avoid excessive erythrocytosis.
  • Target mid-normal total and free testosterone; focus on symptom resolution and safety metrics.

Integrative Chiropractic Care: Biomechanics, Autonomic Balance, and Endocrine Support

Where does integrative chiropractic care fit in?

  • Pain relief and mobility: Reducing nociceptive input lowers the cortisol and catecholamine burden, supporting sex hormone signaling and thyroid function.
  • Autonomic regulation: Cervical and thoracic segmental work may modulate sympathetic-parasympathetic balance, improving sleep, HRV, and stress resilience.
  • Movement prescriptions: Progressive loading enhances insulin sensitivity, bone density, and capillary perfusion—improving hormone absorption and metabolic outcomes.
  • Pelvic alignment and floor function: In heavy bleeding and pelvic pain, optimizing sacral mechanics can reduce cramping and enhance lymphatic drainage, aiding symptom control.
  • Post-bariatric support: Core stabilization and low-impact aerobic plans accommodate altered biomechanics and support long-term weight maintenance.

My clinical observations from ChiroMed:

  • When we combine biomechanical optimization with iron repletion, cyclic progesterone, and metabolic therapy, women report faster improvements in energy and menstrual regularity.
  • In PCOS, structured resistance training guided by chiropractic-informed movement analysis reduces central adiposity and improves ovulatory patterns.
  • In older men on testosterone pellets, a tailored mobility program plus hydration and renal-friendly lifestyle supports steady hormone levels and minimizes adverse effects.

Stepwise Clinical Algorithms and Bullet Points

Heavy bleeding with suspected iron deficiency:

  • Screen: CBC, ferritin, TSAT, CRP, TSH, free T4, free T3.
  • Treat: iron + vitamin C; assess copper and magnesium; cyclic micronized progesterone; address thyroid dysfunction.
  • Follow: ferritin target >50–100 ng/mL depending on symptoms; re-test every 8–12 weeks.
  • Integrate: pelvic biomechanics, stress reduction, sleep support.

PCOS symptom cluster:

  • Labs: fasting insulin, A1c, lipids, LH/FSH, vitamin D; consider ultrasound.
  • Lifestyle: strength + aerobic; high-fiber diet; sleep retraining.
  • Therapy: inositol, magnesium, omega-3; consider metformin/GLP-1; cyclic progesterone for endometrial protection.
  • Chiropractic: movement coaching; pain reduction for adherence.

Post–gastric bypass:

  • Assess: iron, B12, folate, vitamins A/D/E/K, calcium, magnesium, zinc, selenium.
  • Replace: oral vs IV based on tolerance; transdermal hormones favored.
  • GI: targeted probiotics; evaluate SIBO if symptoms persist.
  • Movement: gentle progression to improve perfusion and absorption.

Testosterone optimization:

  • Kinetics: absorption (perfusion), distribution (BMI), excretion (renal).
  • Dosing: titrate after weight change; lower doses in the elderly; avoid supraphysiologic spikes.
  • Monitoring: total/free T, estradiol, hematocrit, PSA (men), symptoms.
  • Avoid routine estrogen blockers; correct underlying kinetics.

Midlife contraception:

  • Reassess need: if no pregnancy risk, minimize systemic estrogen-progestin exposure.
  • Prefer LNG-IUD for bleeding control; use physiologic hormone therapy for symptoms.
  • Consider SHBG effects and tailor accordingly.

SHBG management:

  • Identify contributors: OCPs, thyroid, liver, and insulin resistance.
  • Reduce SHBG influence by changing contraception and optimizing metabolic health.
  • Target free testosterone rather than inflating total levels.

Safety and communication:

  • Educate on risks of overdosing and myths about “extra sessions.”
  • Reinforce adherence and measured titration.
  • Use shared decision-making with transparent lab review.

Conclusion: Precision Protocols with Whole-Person Care

The strongest outcomes arise when we blend precise, physiology-based hormone protocols with integrative chiropractic care and lifestyle medicine. By correcting iron deficiency, stabilizing cycles with progesterone, respecting testosterone kinetics, and rationalizing contraception choices in midlife, we reduce risk and improve quality of life. Each intervention is chosen for a physiologic reason and is tested against symptoms and labs. With careful monitoring and team-based care, patients can achieve durable, meaningful improvements.

References

Wellbeing Guide For Hormone Optimization & Metabolic Health

Discover how a clinical approach to hormone optimization can enhance your metabolic health and overall wellness.

Abstract


In this educational post, I present a clinician-focused, first-person synthesis of modern, evidence-based hormone optimization and systems biology. I integrate the latest findings from leading researchers with my clinical observations to explain how estrogen, testosterone, and progesterone regulate brain, bone, cardiovascular, metabolic, immune, and sexual health. I clarify why bioidentical 17β-estradiol and micronized progesterone differ from synthetic formulations, detail the importance of route, dose, and timing, and review metabolite safety and the gut microbiome’s influence on hormone signaling. I also outline protocols for dosing, delivery modality selection, and monitoring, and provide a systems-based framework for managing risks, side effects, and complications. My goal is to help clinicians and patients understand the mechanisms, translate research into practice, and pursue preventive, physiologic care that improves quality of life and longevity.
Keywords: hormone optimization, estrogen therapy, testosterone therapy, progesterone benefits, bioidentical hormones, transdeestradioladiol, micronized progesterone, androgen receptor, estrogen receptor, estrogen metabolites, COMT, methylation, estrobolome, microbiome, β-glucuronidase, bile acids, insulin sensitivity, bone density, cardiovascular risk, neurosteroids, sleep, erythrocytosis, prostate monitoring, VTE risk, functional medicine, clinical protocols, dosing strategies, side effect management

My Purpose and Preventive Care Perspective

As a clinician trained in functional and integrative medicine, I learned early in my career in urgent care and through exposure to end-of-life care that many emergencies arise from chronic, modifiable diseases. That realization pushed me toward proactive medicine grounded in hormone optimization and systems biology. Today, I combine peer-reviewed research with day-to-day practice insights from El Paso and beyond to deliver precise, safe, and personalized care.
I prioritize evidence-based protocols that restore physiologic ranges, avoiding supraphysiologic exposures that raise risk.
I use mechanism-first reasoning, tracing receptor pharmacology, downstream signaling, metabolic clearance, and tissue-specific effects to guide decisions.
I integrate gut and nutrient strategies to improve receptor sensitivity, metabolite profiles, and clinical outcomes.
Explore my ongoing clinical updates and case-informed reflections:

Why Mechanisms and Literature Must Drive Hormone Care

Persistent misconceptions around cancer risk, cardiometabolic outcomes, and the idea that “all hormones are the same” still influence practice. To correct these, I synthesize high-impact literature and apply physiology.
Core principle: the preventive value of hormones is context-dependent. Risks increase when the dose, delivery route, or metabolism are mismatched with patient physiology, or when monitoring is inadequate (NAMS Position Statement, 2022).
Clinical behavior:
Stratify baseline risk (family history, genomics, comorbidities).
Optimize metabolic and inflammatory terrain.
Select the lowest effective dose that restores function and quality of life while meeting biomarker targets.
This systems-first approach allows genuine prevention rather than symptom suppression.

Estrogen Optimization and Disease Prevention: Molecule, Receptor, and Route

Estrogen is not estradiol (E2), estrone (E1), or estriol (E3); these interconvert and signal via ERα, ERβ, and non-genomic pathways. These distinctions drive outcomes across organ systems.
Cardiometabolic: Estradiol improves endothelial nitric oxide synthase, dampens vascular inflammation, and influences lipoprotein profiles. Loss of E2 after menopause increases arterial stiffness and atherogenesis (Rosano et al., Endothelial effects of estrogen, 2007; Manson et al., WHI outcomes, 2013).
Skeletal: Estrogen reduces osteoclastogenesis via RANKL/OPG and supports osteoblast survival, lowering bone turnover and fracture risk (NAMS Position Statement, 2022).
Neurocognitive: E2 enhances synaptic plasticity, glucose utilization, and mitochondrial biogenesis, with neurosteroid effects modulating GABAergic tone (Brinton, Estrogen-induced plasticity, 2008; Arevalo et al., Estradiol and progesterone modulate brain inflammation, 2015).
Immune and repair: ER signaling tempers NF-κB, influences Treg activity, and supports tissue repair (Arevalo et al., 2015).

Cancer Risk, Metabolites, and Delivery

The question is not “Do hormones cause cancer?” but Whichh hormone, at what dose, via what route, in which patient, with what metabolism?””
Metabolite pathways:
2-hydroxylated estrogens are generally less proliferative.
4-hydroxylated estrogens can form catechol quinones with genotoxic potential.
16α-hydroxylated estrogens carry proliferative signals.
Favoring 2-hydroxylation and enhancing COMT-mediated methylation reduces reactive metabolite burden (Estrogen metabolites and breast cancer risk, 2012; COMT polymorphisms and cancer risk, 2004).
Route matters: Transdermal estradiol avoids hepatic first-pass induction of clotting factors and triglycerides, reducing VTE and metabolic risks compared with oral estrogens (Transdermal vs oral estrogen and vascular risk, 2016; Scarabin, Oral vs transdermal estrogen and VTE, 2003).
Progestogen pairing:
Endometrial protection requires progesterone or a progestin for women with a uterus.
Bioidentical micronized progesterone has more favorable vascular and breast profiles than certain synthetic progestins (Stanczyk et al., Progestins vs progesterone, 2013).

Clinical Protocol Logic

Start low, titrate slowly, and aim for physiologic mid-reference ranges aligned with symptom relief and biomarkers.
Prefer transdeestradiol in higher-risk or migraine-with-aura patients.
Monestradioladiol, estrone, SHBG, TSH, lipids, CRP, and urinary estrogen metabolites when indicated.
Support metabolite safety:
Dietary indoles (crucifers), omega-3s, glycine, and methyl donors as appropriate.
Clinical observation: In active women with estradiol and recurrent stress fractures, transdermal E2 combined with micronized progesterone and targeted micronutrients (calcium, vitamin D3/K2, magnesium, omega-3s) improves bone turnover markers, recovery, and mood. Adding resistance training amplifies skeletal benefits and helps with weight management. See practice insights at https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/.

Testosterone: Anabolism, Metabolism, and Modality Selection

Testosterone reaches beyond muscle to influence erythropoiesis, insulin sensitivity, libido, bone density, mood, and immune tone. Age-related decline intersects with rising SHBG, sleep disruption, adiposity, and inflammation.
Androgen receptor dynamics:
Testosterone signals through the AR, with the balance between coactivators and corepressors affecting tissue outcomes.
Adiposity increases aromatase activity, shifting testosterone toward estradiol and altering feedback loops.
Metabolites:
Conversion to DHT via 5α-reductase impacts prostate, skin, and hair.
Peripheral conversion to E2 is essential for the bone and the brain.
Cardiometabolic:
Physiologic testosterone improves visceral adiposity, HbA1c, and triglycerides; supraphysiologic dosing increases the risk of erythrocytosis and adverse lipid profiles (Endocrine Society Guideline, 2018).

Delivery Modalities

Transdermal gels/creams: steady exposure, titration flexibility; educate on contact transfer precautions.
Injectable (e.g., cypionate): weekly or twice-weekly dosing reduces peaks and troughs affecting mood and hematology.
Subcutaneous pellets: extended release with adherence advantages; less flexible titration.
Oral undecanoate: lymphatic absorption; variable exposures.

Monitoring and Mitigation

Track total/free testosterone, Sestradioladiol, hematocrit/hemoglobin, PSA, lipids, LFTs.
Manage aromatization:
Use body composition interventions first.
Avoid routine use of aromatase inhibitors (AIs) to prevent bone and mood-related adverse effects; use only when clearly indicated.
Address erythrocytosis:
Dose-adjust; increase dosing frequency; evaluate for sleep apnea; consider phlebotomy when necessary.
Clinical observation: Men with obesity and sleep apnea respond best when CPAP adherence and resistance/interval training precede or accompany testosterone. This reduces the need for doses, stabilizes hematocrit, and improves glycemia. For peak–trough irritability, twice-weekly subcutaneous injections improve tolerability. Professional reflections shared at https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/.

Progesterone: Neurosteroid, Sleep Modulator, and Endometrial Protector

Progesterone is a critical neurosteroid that enhances GABA-A activity, stabilizes mood and sleep, and orchestrates endometrial differentiation to oppose estrogen-driven proliferation.
Why bioidentical micronized progesterone:
CNS benefits via allopregnanolone improve sleep initiation and anxiety more consistently than some progestins.
Favorable metabolic effects on lipids and blood pressure compared to certain synthetic analogs.
Essential endometrial protection in women receiving systemic estrogen (Micronized progesterone pharmacology, 2019).
Dosing strategy:
Night dosing aligns with sedative neurosteroid effects.
In perimenopause, cyclic or continuous regimens tailored to symptoms and bleeding.
Adjust dose/route for mastalgia or fluid retention and reassess estrogen dosing and metabolites.
Clinical observation: In perimenopausal patients with sleep maintenance insomnia, nighttime micronized progesterone often reduces awakenings within 1–2 weeks. Combined with sleep hygiene and light therapy, the benefits are durable and reduce reliance on sedative-hypnotics.

Gut Health and the Estrobolome: Amplifying Hormone Receptor Activity

Hormones are effective only within a healthy terrain. The gut microbiome—especially the estrobolome—shapes estrogen recirculation, clearance, and receptor engagement.
Mechanistic links:
β-Glucuronidase excess deconjugates estrogens, driving enterohepatic recirculation and elevating certain metabolites.
Bile acid signaling via FXR and TGR5 intersects with glucose and lipid metabolism, affecting hormone sensitivity.
Barrier integrity: Increased permeability raises LPS levels, provoking TNF-α/IL-6, which can blunt hormone receptor signaling (The estrobolome and women’s health, 2019; Microbiome, bile acids, and metabolic regulation, 2014).
Clinical tools:
Diet emphasizing fiber, polyphenols, and fermented foods to diversify microbiota and modulate β-glucuronidase.
Targeted probiotics with bile salt hydrolase activity when indicated.
Consider calcium D-glucarate for high β-glucuronidase levels while addressing the root causes of diet/dysbiosis.
Support phase II detoxification with glycine, sulfur amino acids, and methyl donors.
Clinical observation: In estrogen-dominant symptom patterns with persistent mastalgia, correcting constipation, optimizing fiber/water intake, and addressing dysbiosis normalizes transit and reduces symptoms within 4–6 weeks, enabling lower hormone doses with better tolerability.

Nutrient Cofactors: Steroidogenesis, Metabolism, and Receptor Sensitivity

Robust hormone therapy requires nutrient sufficiency to support synthesis and clearance.
Zinc: Cofactor for 3β-HSD and 5α-reductase modulation; supports AR function.
Magnesium: Required for ATP-dependent enzymes in steroidogenesis and for insulin sensitivity, which influences SHBG and bioavailable hormones.
Vitamin D: Through VDR, modulates aromatase and immune tone; sufficiency enhances musculoskeletal responses to hormones (Vitamin D and testosterone interplay, 2019).
B vitamins (B2, B6, B12, folate): Support methylation and COMT for catechol estrogen clearance.
Omega-3 fatty acids: Reduce inflammatory tone, improving endothelial and receptor signaling (Omega-3s and endothelial function, 2014).
Choline and glycine: Facilitate phase II conjugation and bile acid metabolism.
Clinical observation: Correcting magnesium deficiency attenuates PVCs and improves sleep in patients starting progesterone. Addressing vitamin D insufficiency improves muscle strength responses to testosterone in older adults.

Finding Hormonal Harmony- Video

Choosing and Managing Hormone Delivery Modalities

Selecting a modality balances pharmacokinetics, safety, lifestyle, and monitoring.
Estrogen modalities:
Transdermal patches/gels: predictable PK, lower VTE risk; patches improve adherence; gels allow fine titration.
estradiol: consider only when benefits outweigh hepatic effects; monitor triglycerides and clotting risk.
Vaginal estradiol/estriol: local therapy for genitourinary syndrome; minimal systemic absorption at low doses.
Progesterone modalities:
Oral micronized progesterone: best for sleep and endometrial protection; take with a small fat-containing snack.
Vaginal progesterone: useful for uterine-focused effects or GI sensitivity.
Levonorgestrel IUD: potent endometrial suppression; useful for bleeding control with systemic estrogen.
Testosterone modalities:
Topical: cautious initiation and fine-tuning; emphasize site precautions.
Injectable: weekly/twice-weekly subcutaneous improves stability; counsel on technique.
Pellets: consider for adherence barriers; anticipate minor surgical risks and less flexible adjustments.
Monitoring cadence: baseline labs; recheck at 6–8 weeks after initiation or change; then every 3–6 months once stable; tailored to risk and symptom trajectory.

Safety, Side Effects, and Complication Management

Every protocol needs a safety net.
VTE risk: Favor transdermal estradiol; address obesity, immobility, smoking; consider thrombophilia screening when history suggests (Transdermal vs oral estrogen and vascular risk, 2016).
Breast health: Use the lowest effective estrogen dose with micronized progesterone; personalize imaging cadence and assess family history; emphasize exercise and alcohol moderation (Chlebowski et al., WHI breast cancer follow-up, 2020).
Prostate: In men, baseline PSA and DRE per guidelines; avoid initiating in untreated high-risk contexts; recheck PSA after stabilization (Endocrine Society Guideline, 2018).
Erythrocytosis: Adjust testosterone, check sleep apnea, ensure hydration; use phlebotomy only when clinically necessary (Sleep apnea and erythrocytosis, 2012).
Mood changes: Avoid sharp injection peaks; consider the topical route or adjust the frequency; evaluate sleep and micronutrient status.
Abnormal uterine bleeding: Verify endometrial protection, evaluate dosing, consider ultrasound; rule out structural causes.
Acne/hirsutism: Dose-adjust and assess DHT; consider 5α-reductase modulation case-by-case and discuss fertility.
Clinical observation: The highest-risk side effects occur when therapy starts without adequate risk stratification or when dose escalation outruns monitoring. Most complications abate with dose correction, route change, and terrain optimization.

Integrating Lifestyle, Behavior, and Shared Decision-Making

Hormones amplify what lifestyle initiates. Without sleep consolidation, resistance training, cardiorespiratory fitness, and nutritional adequacy, hormone therapy underperforms.
Exercise:
Resistance training enhances bone mineral density and insulin sensitivity.
Aerobic work improves endothelial function.
Both attenuate aromatase via fat loss (Exercise and bone metabolism, 2020).
Nutrition:
Adequate protein, fiber, and phytonutrient diversity support the microbiome and detox pathways.
Alcohol moderation reduces estrogenic load and breast risk.
Stress regulation:
Elevated cortisol undermines sex steroid signaling; mind–body practices and sleep hygiene are essential.
I emphasize shared decision-making, present risks and benefits with data, and align plans with patient values. Education transforms adherence and safety.

Practical Algorithm: Putting It All Together

Evaluate baseline: history, goals, cancer/prostate/VTE risk, sleep, mood, cardiometabolic markers, body composition, GI function.
Correct terrain: sleep, nutrition, movement, microbiome support, micronutrient deficits.
Select modality: choose delivery route aligned with risk; start low and titrate based on symptoms and labs.
Support metabolism: use diet and targeted supplements; monitor estrogen metabolites when indicated.
Monitor and adjust: schedule labs and visits; use symptom scores; adjust dose/frequency/route to sustain physiologic targets.
Prevent and manage side effects: anticipate, educate, and intervene early; document shared decisions and outcomes.

EEstrogen’sCritical Window, WHI Misconceptions, and Modern Guidelines

The Women’s Health Initiative (WHI) used conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA), not bioidentical molecules. Early risk signals were concentrated in the progestin arm, yet headlines generalized these findings to all hormones (Manson et al., WHI outcomes, 2013). Subsequent analyses demonstrated nuance:
Estrogen-alone in hysterectomized women showed neutral to beneficial patterns for some endpoints, including breast cancer incidence and mortality (Chlebowski et al., 2020).
The critical window hypothesis supports starting therapy near menopause to optimize vascular and neuroprotective effects (Maki & Henderson, Critical window, 2016).
Modern guidance emphasizes individualization, rejects routine discontinuation at age 65, and supports continuation when risk–benefit is favorable (NAMS 2017 Position Statement, 2017; NAMS 2022 Update, 2022; ACOG Practice Bulletin, 2023).
My practice aligns with these updates by prioritizing bioidentical 17β-estradiol and micronized progesterone, favoring transdermal routes, and personalizing plans.

Estradiol, Cardiovascular and Brain Protection, and Discontinuation Risks

A body of evidence indicates that appropriately destradioladiol improves vascular and metabolic health, reduces events, and supports neuroprotection:
Endothelial benefits via NO synthase activation, reduced NF-κB, improved lipids, and plaque stability (Mendelsohn & Karas, Cardiovascular effects of estrogen, 2005).
Neuroprotection through PI3K/Akt, ERK, BBB integrity preservation, and microglial modulation (Liu et al., Estradiol neuroprotection, 2007; Arevalo et al., 2015).
Abrupt estrogen withdrawal increases cardiac and stroke risks due to autonomic destabilization, vascular tone shifts, and coagulation changes; tapering is safer (Grodstein et al., HT discontinuation CV implications, 2003).
In practice, I counsel patients on continuity and, when needed, careful tapering, while maintaining protective lifestyle interventions.

Testosterone–Estradiol Synergy and Avoiding Aromatase Inhibitors in Men

Estradiol and testosterone synergize to improve lipids, insulin, and visceral fat. Routine AI use can blunt these benefits:
Bisphenol A raises pain sensitivity, worsens metabolic parameters, and undermines bone health (Henry et al., AI musculoskeletal symptoms, 2018; Handelsman, Estrogen in men’s bone health, 2013).
Allowing physiological aromatization supports the integrity of the brain, bone, vascular, and metabolic systems.
I avoid routine AIs, monestradioladiol rather than preemptively blocking it, and use body composition strategies to modulate aromatization.

Sexual Health, Genitourinary Support, and MMen’sEstrogen Balance

Estrogen influences libido, arousal, vaginal mucosa, pelvic floor, and urogenital health. In men, balaestradiol supports libido, endothelium, and bone. I pair estradiol with local therapies (e.g., vagestradiol or DHEA) and pelvic rehab when indicated, while ensuring mmen’sE2/T ratios remain physiological.

My Clinical Observations: Translating Research into Outcomes

From my practice at Chiromed and collaborative care settings:
Women initiating transdermal 17β-estradiol near menopause report rapid improvements in cognition, sleep, and vasomotor symptoms; over 6–12 months, we see improvements in lipids, lower CRP, and better glycemic metrics with nutrition and resistance training.
Adding micronized progesterone stabilizes mood and sleep; patients report deeper, more restorative rest.
Thoughtful androgen support in women can enhance energy, bone, and sexual desire; monitoring hair/skin/lipids guides dosing.
Chronic pain patients often exhibit hormonal insufficiency; corticosteroids and progesterone reduce central sensitization; when combined with myofascial care, strength training, and anti-inflammatory nutrition, outcomes improve.
Deprescribing occurs naturally: fewer sedatives as sleep normalizes, reduced antidepressants with neurosteroid support, lower antihypertensives as endothelial function and autonomic tone improve.
Explore my clinical insights:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Practical Protocol Considerations and Rationale

I design protocols to match physiology, goals, and safety:
Comprehensive assessment:
Menstrual history, vasomotor symptoms, cognition, mood, sexual health, fracture risk, cardiometabolic markers, and family history.
Estradiol:
Initiate transdermal 17β-estradiol for brain, vascular, and bone signaling due to receptor congruence and lower thrombotic risk.
Progesterone:
Add oral micronized progesterone for uterine protection and neurocalm; avoid progestins due to their receptor promiscuity and immune effects.
Androgens:
Consider low-dose testosterone in women for bone, muscle, and libido with careful monitoring; in men, maintain physiologic dosing and avoid routine AIs.
Lifestyle medicine:
Progressive resistance training, zone-2 cardio, sleep optimization, stress management, and a phytonutrient-rich diet.
Gut–hormone axis:
Address dysbiosis, increase fiber and polyphenol intake, support liver detoxification, and normalize enterohepatic cycling.
Monitoring:
Track symptoms, vitals, lipids, CRP, glucose/insulin, DEXA, endometrial status, and cognitive screening as needed.
Each element is chosen to advance patient goals and respect biological signaling.

Myths and Misconceptions Corrected


““strogen causes breast cancer.””Evidence differentiates molecules: risks increased with progestin combinations started late in WHI; estrogen-alone data show neutral/beneficial patterns in specific groups. Bioidentestradiol with progesterone is distinct from CEE+MPA (Chlebowski et al., 2020; NAMS 2022 Update, 2022).
“”ll hormones are the same.””False. 17β-estradiol and micronized progesterone are physiologically coherent; synthetic analogs have different receptor promiscuity and effects (Stanczyk et al., 2013).
“top at 65.” Not evidence-based; discontinuation reverses gains. Continuation should be individualized (NAMS 2017 Position Statement, 2017; NAMS 2022 Update, 2022).
“Only treat hot flashes.””Estrogen is a longevity hormone that affects the brain, bones, heart, immune system, and sexual health.

Conclusion: Modern, Evidence-Based Hormone Optimization

Estrogen, specifically 17β-estradiol, paired with micronized progesterone, and testosterone where appropriate, supports neuroprotection, bone strength, cardiovascular resilience, immune modulation, and sexual vitality. Outcomes depend on molecule, route, dose, timing, and systemic context. By embracing modern evidence and systems biology, we can reduce polypharmacy, elevate quality of life, and practice true preventive medicine.

References

About Dr. Alexander Jimenez

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, provides integrative, functional, and evidence-based musculoskeletal and metabolic care. Clinical insights and educational resources are available at:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Keywords


hormone optimization, estrogen therapy, testosterone therapy, progesterone benefits, bioidentical hormones, transdeestradioladiol, micronized progesterone, androgen receptor, estrogen receptor, estrogen metabolites, COMT, methylation, estrobolome, microbiome, β-glucuronidase, bile acids, insulin sensitivity, bone density, cardiovascular risk, neurosteroids, sleep, erythrocytosis, prostate monitoring, VTE risk, functional medicine, clinical protocols, dosing strategies, side effect management, longevity, preventive medicine

Disclaimer


This educational content is for informational purposes only and does not constitute medical advice. Do not start, stop, or change any medication or therapy without consulting your qualified healthcare provider.

SEO tags: hormone optimization, bioidentestradiol, micronized progesterone, transdermal estrogen safety, testosterone therapy men, aromatase inhibitors risks, menopause brain health, dementia prevention estrogen, cardiovascular endothelial function estrogen, bone density menopause therapy, estrobolome gut hormones, functional medicine hormone therapy, VTE risk transdermal estrogen, progesterone neurosteroid sleep, erythrocytosis testosterone management, Dr. Alexander Jimenez DC APRN FNP-BC, evidence-based endocrinology, WHI misconceptions and modern guidelines, NAMS hormone therapy position, androgen therapy women, deprescribing with hormone optimization